Skip to main content

Diagnostic options Β· UAE

Single Gene Sequencing tests in Dubai & UAE

Compare available Single Gene Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

297

Listed price range

2,800.00–4,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene Sequencing test prices

Showing 61–75 of 297 matching tests.

Single Gene Sequencing diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-2439
COL2A1 Gene Platyspondylic Skeletal Dysplasia, Torrance Type Genetic Test

This test identifies mutations in the COL2A1 gene, providing a definitive diagnosis for Torrance-type platyspondylic skeletal dysplasia.

Whole Blood (EDTA), Extracted DNA, or FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["COL2A1 gene mutations (SNVs, Indels, Large Deletions/Duplications)"]
Parameters
[]
Preparation
["No fasting required", "Patient must be afebrile for 24 hours prior"]
Indications
["Suspected diagnosis of Torrance-type platyspondylic skeletal dysplasia", "Need to differentiate from other COL2A1 phenotypes"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: Q77.7
Clinical summary
This test identifies mutations in the COL2A1 gene, providing a definitive diagnosis for Torrance-type platyspondylic skeletal dysplasia.
TEST-5506
COLEC11 Gene 3MC Syndrome Type 2 Genetic Test

This genetic test identifies pathogenic variants in the COLEC11 gene, confirming a diagnosis of 3MC syndrome type 2.

Blood (whole blood) or Dried Blood Spot (FTA card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the COLEC11 gene"]
Parameters
[]
Preparation
[]
Indications
["Suspected 3MC syndrome type 2", "Family history of 3MC syndrome type 2", "Carrier screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 100430-5 ICD-10: Q87.0, Z14.8, Z83.89
Clinical summary
This genetic test identifies pathogenic variants in the COLEC11 gene, confirming a diagnosis of 3MC syndrome type 2.
TEST-6068
COMT Gene Catechol-O-Methyltransferase Deficiency Genetic Test

This genetic test evaluates the entire COMT gene for pathogenic variants linked to catechol-O-methyltransferase deficiency.

Peripheral Whole Blood (EDTA) or Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["COMT gene sequence", "Pathogenic variants in COMT gene"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Suspected catechol-O-methyltransferase deficiency", "Personal or family history of related conditions", "Guiding medication selection"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 90535-9 ICD-10: E70.8, Z15.8, F79
Clinical summary
This genetic test evaluates the entire COMT gene for pathogenic variants linked to catechol-O-methyltransferase deficiency.
TEST-4883
CORO1A Gene (Immunodeficiency Type 8) Genetic Test

This test identifies pathogenic variants in the CORO1A gene, confirming a diagnosis of severe combined immunodeficiency type 8.

Peripheral whole blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CORO1A gene sequence", "Pathogenic variants in CORO1A"]
Parameters
[]
Preparation
["Completed clinical history form", "Three-generation pedigree", "Pre-test genetic counseling"]
Indications
["Clinical suspicion of inherited immune dysregulation", "Recurrent bacterial or viral skin infections", "Persistent warts", "Family history suggestive of early-onset immune defects"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82266-3 ICD-10: D81.2, D81.8, Z15.89
Clinical summary
This test identifies pathogenic variants in the CORO1A gene, confirming a diagnosis of severe combined immunodeficiency type 8.
TEST-3846
COX20 Gene Ataxia and Muscle Hypotonia Genetic Test

This test identifies pathogenic variants in the COX20 gene associated with mitochondrial complex IV deficiency, cerebellar ataxia, and muscle hypotonia.

Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the COX20 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variants"]
Parameters
[]
Preparation
["No specific fasting required.", "Do not discontinue prescribed medication without consulting your treating physician."]
Indications
["Clinical suspicion of mitochondrial disease", "Unexplained cerebellar ataxia", "Congenital hypotonia with elevated lactate"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101398-2 ICD-10: G31.81, G11.1, P94.2
Clinical summary
This test identifies pathogenic variants in the COX20 gene associated with mitochondrial complex IV deficiency, cerebellar ataxia, and muscle hypotonia.
TEST-5850
CRB2 Gene Ventriculomegaly with Cystic Kidney Disease Genetic Test

This genetic test identifies pathogenic variants in the CRB2 gene associated with ciliopathies affecting brain and kidney development.

Peripheral Whole Blood or Saliva (Oragene DNA Kit) 21 – 28 Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CRB2 gene"]
Parameters
[]
Preparation
["No special preparation like fasting is required", "Pre-test genetic counseling is recommended"]
Indications
["Clinical suspicion of CRB2-associated ciliopathy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101650-8 ICD-10: Q04.8, Q61.9
Clinical summary
This genetic test identifies pathogenic variants in the CRB2 gene associated with ciliopathies affecting brain and kidney development.
TEST-1685
Crigler-Najjar Syndrome Single Gene Sequencing Test

This test identifies mutations in the UGT1A1 gene, which are the cause of Crigler-Najjar syndrome, a rare inherited disorder affecting bilirubin metabolism.

Whole Blood (peripheral) 7–8 working days 3,600.00 AED
View
View test specifications and preparation
What it measures
["UGT1A1 gene mutations", "Bilirubin metabolism pathway defects"]
Parameters
[{"name": "UGT1A1 Gene Sequencing", "reference_range": null}]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication"]
Indications
["Suspected Crigler-Najjar syndrome", "Prenatal diagnosis", "Carrier screening", "Confirmatory testing for jaundice"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21626-6 ICD-10: E80.5
Clinical summary
This test identifies mutations in the UGT1A1 gene, which are the cause of Crigler-Najjar syndrome, a rare inherited disorder affecting bilirubin metabolism.
TEST-5417
CROCC Gene Sequencing Test

This test detects pathogenic variants in the CROCC gene associated with neurodevelopmental disorders.

Peripheral Whole Blood 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CROCC gene", "Copy Number Variants (CNV)", "Structural Variants"]
Parameters
[]
Preparation
["No fasting required", "All standard medications may be continued unless advised otherwise by a physician"]
Indications
["Suspected genetic aetiology for neurodevelopmental disorders", "Unexplained neurodevelopmental delays"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: F88, Z13.39
Clinical summary
This test detects pathogenic variants in the CROCC gene associated with neurodevelopmental disorders.
TEST-5858
CRPPA Gene (Walker-Warburg Syndrome) Genetic Test

This genetic test evaluates the entire coding region of the CRPPA gene for pathogenic variants associated with Walker-Warburg syndrome.

Whole Blood (EDTA), Extracted DNA, FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CRPPA gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)"]
Parameters
[]
Preparation
["No fasting is needed."]
Indications
["Suspected Walker-Warburg syndrome", "Severe congenital muscular dystrophy with brain and eye anomalies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: Q87.8
Clinical summary
This genetic test evaluates the entire coding region of the CRPPA gene for pathogenic variants associated with Walker-Warburg syndrome.
TEST-4907
CUL4B Gene Mental Retardation, X‑Linked Type 15 DNA Test

This test detects pathogenic variants in the CUL4B gene associated with X-linked intellectual disability type 15.

Peripheral Whole Blood, Extracted Genomic DNA, or FTA Card Dried Blood Spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the CUL4B gene", "Coverage of all coding exons and flanking intronic regions"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Individuals with clinical features suggestive of X‑linked intellectual disability type 15", "Family history of X‑linked intellectual disability type 15"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: F78.A1
Clinical summary
This test detects pathogenic variants in the CUL4B gene associated with X-linked intellectual disability type 15.
TEST-1894
CYLD Gene Analysis for Spiegler-Brooke Syndrome (NGS) Test

This test detects germline mutations in the CYLD gene, which are associated with Spiegler-Brooke syndrome (multiple familial trichoepithelioma). It helps in diagnosing the conditio...

Whole Blood (EDTA), Buccal Swab, or Dried Blood Spot (FTA Card) 21–28 Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Germline mutations in the CYLD gene", "Pathogenic variants in coding exons and splice-site regions"]
Parameters
[]
Preparation
["No fasting or dietary restrictions are necessary."]
Indications
["Diagnosis of Spiegler-Brooke syndrome", "Risk assessment for skin adnexal neoplasms", "Cascade screening of family members"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 83403-4 ICD-10: D23.9
Clinical summary
This test detects germline mutations in the CYLD gene, which are associated with Spiegler-Brooke syndrome (multiple familial trichoepithelioma). It helps in diagnosing the condition and assessing risk for related skin tumors.
TEST-2720
DCAF17 Gene Sequencing (Woodhouse-Sakati Syndrome) Genetic Test

This genetic test sequences the DCAF17 gene to detect variants associated with Woodhouse-Sakati syndrome.

Whole Blood (EDTA), Buccal Swab, or Dried Blood Spot (FTA Card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["DCAF17 gene sequence", "Pathogenic variants in DCAF17"]
Parameters
[]
Preparation
["Pre-test genetic counselling is mandatory", "Provide complete medication list"]
Indications
["Suspected Woodhouse-Sakati syndrome", "Family history of Woodhouse-Sakati syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21600-8 ICD-10: E88.89
Clinical summary
This genetic test sequences the DCAF17 gene to detect variants associated with Woodhouse-Sakati syndrome.
TEST-5797
DIAPH3 Gene Auditory Neuropathy (Autosomal Dominant) Genetic Test

This test identifies pathogenic variants in the DIAPH3 gene associated with autosomal dominant auditory neuropathy spectrum disorder (ANSD).

Peripheral whole blood (5 mL) or buccal swab 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["DIAPH3 gene mutations", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)"]
Parameters
[]
Preparation
["No fasting required", "Provide detailed clinical history of hearing loss", "Provide previous audiology reports", "List current medications"]
Indications
["Diagnosis of autosomal dominant auditory neuropathy", "Carrier screening in families with known DIAPH3 mutations", "Genetic counselling for affected families"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 19239-6 ICD-10: H90.5
Clinical summary
This test identifies pathogenic variants in the DIAPH3 gene associated with autosomal dominant auditory neuropathy spectrum disorder (ANSD).
TEST-2453
DIS3L2 Gene Perlman Syndrome Genetic Test

This test evaluates the DIS3L2 gene for pathogenic variants associated with Perlman syndrome.

Peripheral Whole Blood (EDTA) or Extracted DNA 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["DIS3L2 gene sequence", "Pathogenic variants"]
Parameters
[]
Preparation
[]
Indications
["Suspected Perlman syndrome", "Congenital overgrowth disorder", "Wilms tumor surveillance planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 99534-4 ICD-10: Q87.8
Clinical summary
This test evaluates the DIS3L2 gene for pathogenic variants associated with Perlman syndrome.
TEST-2926
DISP1 Gene Craniofacial & Neurodevelopmental Abnormalities Genetic Test

This test evaluates the DISP1 gene for pathogenic variants associated with craniofacial malformations and neurodevelopmental delay.

Peripheral whole blood 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Single Nucleotide Variants (SNVs)", "Small Insertions/Deletions (indels)", "Copy Number Variants (CNVs)"]
Parameters
[]
Preparation
[]
Indications
["Diagnostic confirmation of suspected DISP1-related disorders", "Genetic risk assessment for family members"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 76679-8 ICD-10: Q04.2, Q87.0, Z15.89
Clinical summary
This test evaluates the DISP1 gene for pathogenic variants associated with craniofacial malformations and neurodevelopmental delay.

Category overview

Single Gene Sequencing: overview

Achieving a definitive diagnosis for a monogenic disorder often requires reading the entire genetic code of a specific gene to find elusive errors. As an elite subspecialty within our Genetics department, Single Gene Sequencing expansively scans the entirety of a single targeted gene to uncover rare or novel mutations. Utilizing state-of-the-art diagnostic technology, this comprehensive molecular screening provides the critical clarity needed to establish a firm diagnosis, safely guiding customized medical management and targeted therapeutic interventions. Consistently ranked among the top diagnostic labs in the UAE, DNA Labs guarantees the utmost in patient confidentiality, uncompromising analytical accuracy, and prompt, reliable reporting. Find the clear, definitive answers you needβ€”schedule your single gene sequencing testing in UAE, arrange a comfortable home sample collection, or contact our specialized medical genetics professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.